| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |